GLENMARK PHARMACEUTICALS USA for GLENMARK PHARMACEUTICALS USA
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicaid Generics Penalty
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT ERDEL | — |
Health Issues HCR
S. 64, Preserve Access to Affordable Generics and Biosimilars Act HR 938, BLOCKING Act HR 1499, Protecting Consumer Access to Generic Drugs Act of 2019 HR 1506, FAIR Generics Act
Foreign entity interest: Glenmark Pharmaceuticals Inc. USA (GPI) is the North American division of Glenmark Pharmaceuticals, Ltd. (GPL), a corporation formed under the laws of India. GPL, as GPIs upstream foreign parent, has an interest in the listed issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GRANT ERDEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.